Ayala Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
12.00
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.49
|
-0.66
|
-0.17
|
-34.69%
|
|
2022-06-30
|
-0.65
|
-0.54
|
0.11
|
16.92%
|
|
2022-03-31
|
-0.68
|
-0.66
|
0.02
|
2.94%
|
|
2021-12-31
|
-0.61
|
-0.66
|
-0.05
|
-8.20%
|
|
2021-09-30
|
-0.80
|
-0.68
|
0.12
|
15.00%
|
|
2021-06-30
|
-0.63
|
-0.75
|
-0.12
|
-19.05%
|
|
2021-03-31
|
-0.71
|
-0.74
|
-0.03
|
-4.23%
|
|
2020-12-31
|
-0.58
|
-0.73
|
-0.15
|
-25.86%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.86
|
|
2021-12-31
|
-2.83
|
|
2020-12-31
|
-3.38
|
|
2019-12-31
|
0.00
|